The Board of Optometry met on July 18, 2019 in Orlando regarding adding Rocklatan to the formulary; the board dismissed the request as name-brands cannot be added, and the combined ingredients are already on the formulary.
More Latest News
November 15, 2023
MQA is planning to revamp the board websites. Please take the survey to give us your recommendations by clicking the survey icon below. Survey closing Friday, 2/2/2024 at 4:30 PM ET Continue reading
November 1, 2023
An annual publication showcasing trends and information about Florida’s health care regulatory landscape. Continue reading